日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Identification of Marker Peptides in Gelatins from Sika Deer (Cervus nippon) Using Ultra-High-Performance Liquid Chromatography-Quadrupole-Exactive-Orbitrap Mass Spectrometry

利用超高效液相色谱-四极杆-Exactive-Orbitrap质谱法鉴定梅花鹿（Cervus nippon）明胶中的标志肽

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules30071528
Otsuki, Kouharu; Nomizo, Aya; Zhang, Mi; Li, Dongxia; Kikuchi, Takashi; Li, Wei
发表日期：2025
文献求助 收藏

Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated Lung Adenocarcinoma via Survivin Downregulation

新型TEAD1抑制剂VT103通过下调Survivin增强达拉非尼在BRAF V600E突变肺腺癌中的疗效

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70075
Hosoya, Kazutaka; Ozasa, Hiroaki; Yoshida, Hironori; Ajimizu, Hitomi; Tsuji, Takahiro; Yamazoe, Masatoshi; Ogimoto, Tatsuya; Hashimoto, Kentaro; Funazo Yamamoto, Tomoko; Suminaga, Keiichiro; Shima, Yusuke; Yoshida, Hiroshi; Nomizo, Takashi; Ito, Hiroaki; Terada, Kazuhiro; Nishikawa, Shigeto; Menju, Toshi; Yoshizawa, Akihiko; Date, Hiroshi; Hirai, Toyohiro
Survivin
肿瘤
BRAF
肿瘤免疫
发表日期：2025
文献求助 收藏

Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective study

培美曲塞治疗肾功能不全的非小细胞肺癌患者的安全性和有效性：一项回顾性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13785-x
Shima, Yusuke; Yoshida, Hironori; Suminaga, Keiichiro; Yoshida, Hiroshi; Hashimoto, Kentaro; Ogimoto, Tatsuya; Hosoya, Kazutaka; Ajimizu, Hitomi; Funazo, Tomoko; Nomizo, Takashi; Ozasa, Hiroaki; Hirai, Toyohiro
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study

PD-L1多态性对免疫检查点抑制剂疗效的影响取决于肿瘤比例评分：一项回顾性研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-024-06081-x
Suminaga, Keiichiro; Nomizo, Takashi; Yoshida, Hironori; Ozasa, Hiroaki
PD-L1
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Durvalumab consolidation after chemoradiotherapy for locoregional recurrent non-small cell lung cancer

度伐利尤单抗巩固治疗局部区域复发性非小细胞肺癌放化疗后

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2025.2879
Suminaga, Keiichiro; Yoshida, Hironori; Shima, Yusuke; Yoshida, Hiroshi; Hashimoto, Kentaro; Ogimoto, Tatsuya; Hosoya, Kazutaka; Funazo, Tomoko; Ajimizu, Hitomi; Nomizo, Takashi; Yoneyama, Masahiro; Kishi, Noriko; Ozasa, Hiroaki; Hirai, Toyohiro
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Successful treatment of lung cancer coexisting with B‑cell lymphoma with pembrolizumab following rituximab‑included chemotherapy: A case report

利妥昔单抗联合化疗后，帕博利珠单抗成功治疗合并B细胞淋巴瘤的肺癌：病例报告

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2024.2731
Natori, Daisuke; Ozasa, Hiroaki; Shima, Yusuke; Mizumoto, Chisaki; Suminaga, Keiichiro; Nomizo, Takashi; Ajimizu, Hitomi; Yoshida, Hironori; Hirai, Toyohiro
B细胞
肺癌
肿瘤
肿瘤免疫
淋巴瘤
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer

CD47多态性预测晚期非小细胞肺癌患者接受纳武利尤单抗治疗的获益

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2023.13950
Ogimoto, Tatsuya; Ozasa, Hiroaki; Yoshida, Hironori; Nomizo, Takashi; Funazo, Tomoko; Yoshida, Hiroshi; Hashimoto, Kentaro; Hosoya, Kazutaka; Yamazoe, Masatoshi; Ajimizu, Hitomi; Tsuji, Takahiro; Sakamori, Yuichi; Kuninaga, Kiyomitsu; Morita, Satoshi; Hirai, Toyohiro
肺癌
肿瘤
T细胞
肿瘤免疫
CD47
细胞生物学
CD4
发表日期：2023
文献求助 收藏

Vestigial-like family member 3 stimulates cell motility by inducing high-mobility group AT-hook 2 expression in cancer cells

退化样家族成员 3 通过诱导癌细胞中的高迁移率族 AT-hook 2 表达来刺激细胞迁移

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.3
doi:10.1111/jcmm.17279
Naoto Hori, Yuki Takakura, Ayumi Sugino, Shuto Iwasawa, Kota Nomizo, Naoto Yamaguchi, Hiroyuki Takano, Noritaka Yamaguchi
肿瘤
肿瘤细胞
WB
发表日期：2022
文献求助 收藏

Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab

度普利尤单抗治疗后嗜酸性肉芽肿性血管炎

期刊:Journal of Allergy and Clinical Immunology Global
影响因子:
doi:10.1016/j.jacig.2022.03.006
Yamazaki, Kai; Nomizo, Takafumi; Hatanaka, Kazuhito; Hayama, Naoki; Oguma, Tsuyoshi; Asano, Koichiro
炎症/感染
发表日期：2022
文献求助 收藏

Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis

过氧化物酶体增殖激活受体 α 介导阿托伐他汀对实验性结肠炎的有益作用

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2021.618365
Paulo José Basso, Helioswilton Sales-Campos, Viviani Nardini, Murillo Duarte-Silva, Vanessa Beatriz Freitas Alves, Giuliano Bonfá, Cassiano Costa Rodrigues, Bruno Ghirotto, Javier Emílio Lazo Chica, Auro Nomizo, Cristina Ribeiro de Barros Cardoso
信号转导
免疫
肠炎
发表日期：2021
文献求助 收藏